Global Bipolar Disorder Therapeutics Market 2019–2023| Increasing R&D Funding to

Posted by Loise Williams on November 20th, 2019

The increasing strategic alliances are one of the major trends being witnessed in the global bipolar disorder therapeutics market 2019-2023. Vendors are focusing on strategic alliances to enter the market. As a result of the entry of several new vendors, the competition in the market is intensifying, and the profit margins of vendors are decreasing. To maintain their market position, the key vendors are entering strategic alliances to strengthen their product portfolio in new regions.

Download the free sample report @ http://bit.ly/2Xy4Asx

Global bipolar disorder therapeutics market: Increasing R&D funding

The rise in the incidence of chronic diseases has encouraged public and private sectors to work on improving the healthcare infrastructure and increasing the healthcare expenditure to provide advanced solutions.

According to a senior analyst at Technavio, “The growth of the healthcare industry is supported by the increase in R&D, which leads to improved diagnosis and treatment of CNS ailments. For instance, the NIH’s R&D funding for bipolar disorder increased from USD 80 million in 2015 to USD 88 million in 2017. Such significant investments in R&D will encourage vendors to introduce novel therapeutics for bipolar disorder, thus supporting the growth of the market.”

Global bipolar disorder therapeutics market: Segmentation analysis

The global bipolar disorder therapeutics market research report provides market segmentation by product (antipsychotics, anticonvulsants, traditional mood stabilizers, and others) and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.

The antipsychotics segment held the largest market share in 2018, contributing to over 45% of the market. This product segment will continue to dominate the global market throughout the forecast period.

The Americas held the largest share of the market in 2018, accounting for more than 52% share, followed by EMEA and APAC respectively. The region is expected to continue to dominate the market during the forecast period.